A major concern for Hodgkin's Disease (HD) survivors is the development of recurrence or second primary tumors. Although factors responsible for the unfavorable outcomes and poor survival of HD patients remain incompletely understood, the population at highest risk seems to be genetically predisposed. In this proposal we propose to evaluate a panel of susceptibility biomarkers as predictors of disease outcome in an existing cohort of 254 HD patients for whom demographic, epidemiological, clinical data and pretreatment blood samples are available. We will test the hypothesis that unfavorable outcomes occur more frequently in patients with poor DNA repair capacity (measures by increase chromosome instability) and with adverse genotypes (polymorphisms in DNA repair and cell cycle control) as compared with patients with favorable outcome. Specifically we propose: 1) To collect follow-up information on health and vital status data to ascertain endpoints (recurrence or second primary tumors) for all the HD patients in the cohort; 2) To phenotypically characterize the role of background chromosomal instability (measured by chromosome aberrations and sister chromatid exchanges) in disease recurrence or development of SPTs. We hypothesize that patients with poor outcomes exhibit higher levels of baseline chromosomal damage than patients with favorable outcome. 3) To elucidate the role that specific polymorphisms in DNA repair capacity genes (XRCC1, XPD and XRCC3) and cell cycle control (p53 gene) play in the modulation of HD outcome. We hypothesize that individuals with DNA repair allelic variants have altered DNA repair capacity and increased risk of developing recurrence or SPT. Similarly, the allelic variants of p53 gene are associated with variant proteins that may alter cell cycle control encouraging progression either by inducing genomic instability and DNA misrepair or by permitting survival of mutants which will in turn have a negative impact on outcome; and 4) To analyze epidemiological and biomarker data independently and jointly as predictors of recurrence and development of SPTs. Identification of subgroups of HD patients who are at increased risk for recurrence or second primary tumor development has both clinical and prognostic relevance. The high risk population can be targeted for intensive preventive and early detection strategies.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
5R01CA098549-03
Application #
6919925
Study Section
Epidemiology and Disease Control Subcommittee 2 (EDC)
Program Officer
Silkensen, Shannon M
Project Start
2003-08-01
Project End
2008-05-31
Budget Start
2005-08-01
Budget End
2006-05-31
Support Year
3
Fiscal Year
2005
Total Cost
$268,780
Indirect Cost
Name
University of Texas MD Anderson Cancer Center
Department
Type
Schools of Medicine
DUNS #
800772139
City
Houston
State
TX
Country
United States
Zip Code
77030
McHugh, Michelle K; Lopez, Mirtha S; Ho, Chung-Han et al. (2013) Use of the cytokinesis-blocked micronucleus assay to detect gender differences and genetic instability in a lung cancer case-control study. Cancer Epidemiol Biomarkers Prev 22:135-45
Monroy, Claudia M; Cortes, Andrea C; Lopez, Mirtha et al. (2011) Hodgkin lymphoma risk: role of genetic polymorphisms and gene-gene interactions in DNA repair pathways. Mol Carcinog 50:825-34
Piskac-Collier, Amanda L; Monroy, Claudia; Lopez, Mirtha S et al. (2011) Variants in folate pathway genes as modulators of genetic instability and lung cancer risk. Genes Chromosomes Cancer 50:1-12
Rondelli, Catherine M; El-Zein, Randa A; Wickliffe, Jeffrey K et al. (2010) A comprehensive haplotype analysis of the XPC genomic sequence reveals a cluster of genetic variants associated with sensitivity to tobacco-smoke mutagens. Toxicol Sci 115:41-50
El-Zein, Randa A; Monroy, Claudia M; Cortes, Andrea et al. (2010) Rapid method for determination of DNA repair capacity in human peripheral blood lymphocytes amongst smokers. BMC Cancer 10:439
Kinslow, Carla J; El-Zein, Randa A; Rondelli, Catherine M et al. (2010) Regulatory regions responsive to oxidative stress in the promoter of the human DNA glycosylase gene NEIL2. Mutagenesis 25:171-7
El-Zein, Randa; Monroy, Claudia M; Etzel, Carol J et al. (2009) Genetic polymorphisms in DNA repair genes as modulators of Hodgkin disease risk. Cancer 115:1651-9
El-Zein, Randa A; Fenech, Michael; Lopez, Mirtha S et al. (2008) Cytokinesis-blocked micronucleus cytome assay biomarkers identify lung cancer cases amongst smokers. Cancer Epidemiol Biomarkers Prev 17:1111-9
Kinslow, Carla J; El-Zein, Randa A; Hill, Courtney E et al. (2008) Single nucleotide polymorphisms 5'upstream the coding region of the NEIL2 gene influence gene transcription levels and alter levels of genetic damage. Genes Chromosomes Cancer 47:923-32
Deng, Cheng Z; Fons, Michael P; Rosenblatt, Judah et al. (2006) Nickel potentiates the genotoxic effect of benzo[a]pyrene in Chinese hamster lung V79 cells. Environ Mol Mutagen 47:150-61

Showing the most recent 10 out of 14 publications